Preferred Label : localization-related epilepsy, nos;
Origin ID : DA-31400;
UMLS CUI : C0014547;
- Automatic exact mappings (from CISMeF team)
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- ICD-10 exact mapping(s)
- Metaterm(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.cochrane.org/fr/CD008841/EPILEPSY_le-lacosamide-en-traitement-adjuvant-dans-lepilepsie-focale
2021
France
United Kingdom
review of literature
french abstract
Epilepsy
Epilepsy
adjuvant, nos
epilepsy
Lacosamide
epilepsies, partial
localization-related epilepsy, nos
epilepsy
---
https://www.cochrane.org/fr/CD012433/EPILEPSY_oxcarbazepine-en-traitement-dappoint-pour-lepilepsie-focale-resistante-aux-medicaments
2020
France
United Kingdom
review of literature
french abstract
epilepsy
Oxcarbazepine
localization-related epilepsy, nos
drug, nos
drug therapy
Epilepsy
epilepsies, partial
Epilepsy
diffuse rigidity
Drug Resistant Epilepsy
epilepsy
drug therapy
---
https://www.cochrane.org/fr/CD009887/EPILEPSY_stiripentol-comme-traitement-adjuvant-de-lepilepsie-focale-resistante-aux-medicaments-epilepsie
2018
United Kingdom
review of literature
french abstract
unilateral
cerebrum
stiripentol
Epilepsy
localization-related epilepsy, nos
ribs
drug builder
chemotherapy, adjuvant
epilepsy
diffuse rigidity
epilepsies, partial
Epilepsy
stiripentol
Drug Resistant Epilepsy
---